About Alkem Laboratories Ltd

Alkem Laboratories Limited is an Indian pharmaceutical company based in Mumbai, Maharashtra, India. Established in 1973 by Mr. Samprada Singh, the company manufactures and sells branded generics, generic drugs, active pharmaceutical ingredient (APIs) and neutraceuticals both in India and internationally in 55 countries (mainly the US), including Australia, Europe, South East Asia, Latin America, Africa and CIS.

 

The company has a wide ranging presence in the acute and chronic therapeutic segments such as Anti-infectives, Gastro-intestinal, Pain Management, Vitamins, Minerals and Nutrition, Central Nervous System, Anti-diabetic, Anti-osteoporosis, Anti-malarial, Cardiovascular, Immunosuppressants and Nutraceutical segments.

 

As per its September 2015 figures, the company:

 

  • Had a portfolio of 736 branded generic drugs

  • Had 13 of its brands featured among the top 300 brands in India

  • Was one of India’s top 10 pharmaceutical companies (in terms of domestic sales) for the past 12 years

  • Had 16 manufacturing facilities (all cGMP compliant):

    • 14 were in India

    • 2 were in US

    • 5 facilities were US FDA, TGA, UK MHRA approved

  • Had 4 R&D facilities (2 in India and 2 in the US) employing 438 scientists

 

Ranked 5 in the Indian pharmaceutical market in terms of domestic sales in the fiscal year 2015, the company enjoys a domestic market leadership in the following segments

 

  • Ranked 1 in anti-infectives, with an 11.2% market share

  • Ranked 3 in gastro-intestinals with a 5.6% market share

  • Ranked 3 in pain/analgesics with a 5% market share

  • Ranked among the top 10 in vitamins, minerals, nutrients and gynecology

  •  

Alkem Laboratories Limited is listed on the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE).

 

Alkem Laboratories Limited at-a-glance

 

  • Sales Turnover USD 556 million
  • Employees 13,132
  • Field Force 5856
  • Stockists 6576
  • Markets Served (countries) 55
  • Manufacturing Facilities 16
  • R&D Centers 4
  • ANDAs filed in the US 66
  • Other Countries 983
  • (Dossiers for each strength)

 

*Source:

http://www.alkemlabs.com/, http://www.alkemlabs.com/sites/default/files/files/Annual-report-2015.pdf

Certifications US FDA

TGA

UK MHRA

MCC

 

 

 

 

 

History of Alkem Laboratories Limited

 

Alkem Laboratories Limited was established in 1973 as a healthcare marketing firm by founders, Mr. Samprada Singh and his brother, Mr. BN Singh. It started manufacturing in 1978, when it established its first plant at Taloja, Mumbai.

 

Since its incorporation in 1973, the company has grown significantly.

 

  • In the fiscal year 2015, it was the 5th largest pharmaceutical company in India in terms of domestic sales.
    (Source: IMS Health)

  • Its domestic business grew at a CAGR of 14.2% from fiscal year 2011 to fiscal year 2015, which was faster than the Indian pharmaceutical industry’s growth of CAGR of 12.2%. (Source: IMS SSA MAT March 2015)

  • It was the 3rd fastest growing company among India’s top 10 domestic pharma companies by sales between the fiscal year 2011 to 2015.
    (Source: IMS SSA MAT March 2015)

 

Milestones

 

  • 1973 – Starts operations as a healthcare marketing company

  • 1978

    • Establishes first plant at Taloja, Mumbai

    • Alkem Laboratories Limited is incorporated

  • 1992 – Establishes manufacturing facility in Mandura, Maharashtra (converted into an API facility in 2005)

  • 2003 – Sets up an in-house R&F facility for ANDA development at Taloja

  • 2006 – Taxim becomes the first anti-infective drug in the Indian pharmaceutical industry to cross INR 1,000 million in domestic sales

  • 2007 – Files first ANDA in the US for the Amlodipine

  • 2009 – Acquires Australian generic pharma company, Pharmacor Pty Ltd.,

  • 2009 – Receives first ANDA approval in US for Amlodipine

  • 2010 – Acquires US generic marketing company, Ascend Laboratories

  • 2011 – Acquires Enzene, an Indian company engaged in the development of biosimilars

  • 2012 – Acquires an API manufacturing facility in the US

  • 2013 – Acquires another API manufacturing facility in the US

  • 2014 – Clavam crosses INR 2,000 million in domestic sales in India

  • 2014 – Acquires the “Clindac-A” brand in India from Galderma S.A.

  • 2015 – Acquires a formulation manufacturing facility in the US

 

BOARD OF DIRECTORS

  • Founders: Mr. Samprada Singh, Mr. BN Singh

  • Chairman Emeritus: Mr. Samprada Singh

  • Executive Chairman: Mr. BN Singh

  • Joint Managing Director: Mr. DK Singh

  • Joint Managing Director: Mr. Sandeep Singh

  • Directors: Mr. BP Singh, Mr. MK Singh, Mr. AK Purwar, Mr. RL Shenoy, Ms. Sudha Ravi, Ms. Sangeeta Singh, Mr. AM Prasad,  Mr. MC Shah

  • Chief Executive Officer: Mr. Prabhat Agrawal

  • Chief Financial Officer: Mr. Rajesh Dubey

  • Sr. VP – Legal & Company Secretary: Mr. Manish Narang

 

Alkem Laboratories Limited Contact Details

 

HEAD OFFICE

Alkem Laboratories Limited

Devashish Building, Alkem House

Senapati Bapat Road, Lower Parel

Mumbai – 400 013

India

 

 

Email: contact@alkem.com

Phone: +91-22-3982 99 99

 

INVESTOR RELATIONS

Mr. Gagan Borana

Alkem House, Senapati Bapat Marg

Lower Parel

Mumbai – 400013

India

 

Email: gagan.borana@alkem.com

Phone: +91-22-3982-9960

Fax: +91-22-2492-7190

 

 

Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...